Omega-3 Fatty Acid Formulations in Cardiovascular Disease: Dietary Supplements are Not Substitutes for Prescription Products Jonathan Fialkow Current Opinion Open access 30 April 2016 Pages: 229 - 239
Triple Combination Therapy for Global Cardiovascular Risk: Atorvastatin, Perindopril, and Amlodipine Michel E. BertrandCharalambos VlachopoulosJean-Jacques Mourad Review Article 02 June 2016 Pages: 241 - 253
The Different Therapeutic Choices with ARBs. Which One to Give? When? Why? Csaba András Dézsi Review Article Open access 03 March 2016 Pages: 255 - 266
Plasma Vitamin K1 Levels in Italian Patients Receiving Oral Anticoagulant Therapy for Mechanical Heart Prosthesis: A Case–Control Study Arturo CafollaAlessandra GentiliRoberta Curini Original Research Article 15 April 2016 Pages: 267 - 274
Drug Interaction Between Clopidogrel and Ranitidine or Omeprazole in Stable Coronary Artery Disease: A Double-Blind, Double Dummy, Randomized Study Remo Holanda de Mendonça FurtadoRobert Patrick GiuglianoJosé Carlos Nicolau Original Research Article 11 June 2016 Pages: 275 - 284
A State Transition Model for Health Outcomes Associated with Vorapaxar Treatment as an Add-on to Standard Care Antiplatelet Therapy in the Prevention of Thrombotic Events for Patients with a Recent Myocardial Infarction John D. WhalenGlenn DaviesIpek Ozer-Stillman Original Research Article 04 June 2016 Pages: 285 - 295
Idarucizumab: A Review as a Reversal Agent for Dabigatran Yahiya Y. Syed Adis Drug Evaluation 07 July 2016 Pages: 297 - 304
65th Annual Scientific Sessions of the American College of Cardiology: 2–4 April 2016; Chicago, IL, USA Amitabh Prakash Meeting Report 25 June 2016 Pages: 305 - 308